At $4,500 for a round of treatment for Covid-19, remdesivir,
That’s the maximum price that the Institute for Clinical and Economic Review recommended for a 10-day treatment of Gilead’s remdesivir, which received
When you are talking about saving a life, that $4,500 “seems really reasonable,” Piper Sandler’s
A number of Wall Street analysts have been
At $4,500 per patient, remdesivir “would have a gross margin and overall profit contribution that is below the company’s other products, but not highly dilutive to the company’s future profitability outlook,” Leerink’s
ICER’s estimate rests on remdesivir showing a mortality benefit. The nonprofit agency said if the company is looking to simply recover the costs of producing it, a 10-day treatment regimen should cost about $10. That figure doesn’t include the cost of research and development as remdesivir was previously developed for hepatitis C, ICER said.
A $1 per day pricing for the treatment rung true for one consumer group, Public Citizen, which claimed that should be enough to cover the manufacturing costs and “a reasonable profit” to the Foster City, California-based Gilead.
“If Gilead intends to price remdesivir at more than $1 per day, Gilead must fully disclose its research and development costs and all public contributions associated with remdesivir’s development. Then payers and independent experts can analyze again what constitutes fair pricing in a pandemic,” Peter Maybarduk, director at the consumer advocacy organization, said in a statement.
Gilead is no stranger to drug-pricing debates after
The stock was up as much as 2.3% in early U.S. trading Monday, and pared some midday losses after the head of the World Health Organizations’ health emergencies program said it planned to engage in talks with the biotechnology company on how the drug may be made more
(Updates shares, adds Public Citizen, WHO commentary)
To contact the reporter on this story:
To contact the editors responsible for this story:
© 2020 Bloomberg L.P. All rights reserved. Used with permission.